Welcome to LookChem.com Sign In|Join Free

CAS

  • or
ETHYL 2-CYANO-3-[4-(TRIFLUOROMETHYL)PHENYL]ACRYLATE is a colorless liquid chemical compound with the molecular formula C13H9F3NO2, possessing a molecular weight of 261.21 g/mol. It is widely recognized for its versatility in organic chemistry due to its ability to participate in a range of chemical reactions, making it a valuable intermediate in the synthesis of various compounds.

149550-21-0

Post Buying Request

149550-21-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

149550-21-0 Usage

Uses

Used in Pharmaceutical Industry:
ETHYL 2-CYANO-3-[4-(TRIFLUOROMETHYL)PHENYL]ACRYLATE is used as a key intermediate in the synthesis of pharmaceuticals for its ability to contribute to the development of new drugs with specific therapeutic properties.
Used in Agrochemical Industry:
In the agrochemical sector, ETHYL 2-CYANO-3-[4-(TRIFLUOROMETHYL)PHENYL]ACRYLATE is utilized as a building block in the creation of agrochemicals, playing a crucial role in the formulation of effective pesticides and other agricultural products.
Used in Polymer Production:
ETHYL 2-CYANO-3-[4-(TRIFLUOROMETHYL)PHENYL]ACRYLATE is employed as a monomer in the production of polymers, contributing to the development of materials with unique properties for various applications.
Used in Adhesive and Coating Industries:
ETHYL 2-CYANO-3-[4-(TRIFLUOROMETHYL)PHENYL]ACRYLATE is also used as a component in the manufacture of adhesives and coatings, enhancing the performance and durability of these products.
It is important to handle and store ETHYL 2-CYANO-3-[4-(TRIFLUOROMETHYL)PHENYL]ACRYLATE with proper safety measures due to its potential hazardous nature, ensuring the well-being of workers and the environment.

Check Digit Verification of cas no

The CAS Registry Mumber 149550-21-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,9,5,5 and 0 respectively; the second part has 2 digits, 2 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 149550-21:
(8*1)+(7*4)+(6*9)+(5*5)+(4*5)+(3*0)+(2*2)+(1*1)=140
140 % 10 = 0
So 149550-21-0 is a valid CAS Registry Number.
InChI:InChI=1/C13H10F3NO2/c1-2-19-12(18)10(8-17)7-9-3-5-11(6-4-9)13(14,15)16/h3-7H,2H2,1H3/b10-7-

149550-21-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name Ethyl 2-cyano-3-[4-(trifluoromethyl)phenyl]-acrylate

1.2 Other means of identification

Product number -
Other names ethyl 2-cyano-3-[4-(trifluoromethyl)phenyl]prop-2-enoate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:149550-21-0 SDS

149550-21-0Downstream Products

149550-21-0Relevant articles and documents

Basic Ionic Liquid Promoted Domino Knoevenagel–Thia-Michael Reaction: An Efficient and Multicomponent Strategy for Synthesis of 1,3-Thiazines

Siddiqui,Rahila,Shamim, Shayna,Rai, Pragati,Shireen,Waseem, Malik A.,Srivastava, Arjita,Srivastava, Anjali

, p. 1284 - 1291 (2016)

An efficient, three-component strategy for synthesis of 1,3-thiazines with high atom economy in one-pot mediated by room temperature basic ionic liquid is described here. The strategy involves basic ionic liquid, [bmim]OH-catalyzed Knoevenagel condensatio

Solid superbase derived from lanthanum-magnesium composite oxide and its catalytic performance in the knoevenagel condensation under solvent-free condition

Wei, Yudan,Zhang, Shuguo,Yin, Shuangfeng,Zhao, Chang,Luo, Shenglian,Au, Chak-Tong

, p. 1333 - 1338 (2011)

We report for the first time the synthesis of a novel solid superbase that was derived from lanthanum-magnesium composite oxide and KOH through thermal treatment. The as-prepared material shows base strength (H-) above 26.5 and is a high-effici

Development of Novel Mitochondrial Pyruvate Carrier Inhibitors to Treat Hair Loss

Liu, Xiaoguang,Flores, Aimee A.,Situ, Lisa,Gu, Wen,Ding, Hui,Christofk, Heather R.,Lowry, William E.,Jung, Michael E.

, p. 2046 - 2063 (2021/02/16)

Herein, we report the synthesis and evaluation of novel analogues of UK-5099 both in vitro and in vivo for the development of mitochondrial pyruvate carrier (MPC) inhibitors to treat hair loss. A comprehensive understanding of the structure-activity relationship was obtained by varying four positions of the hit compound, namely, the alkyl group on the N1 position, substituents on the indole core, various aromatic and heteroaromatic core structures, and various Michael acceptors. The major discovery was that the inhibitors with a 3,5-bis(trifluoromethyl)benzyl group at the N1 position were shown to have much better activity than JXL001 (UK-5099) to increase cellular lactate production. Additionally, analogue JXL069, possessing a 7-azaindole heterocycle, was also shown to have significant MPC inhibition activity, which further increases the chemical space for drug design. Finally, more than 10 analogues were tested on shaved mice by topical treatment and promoted obvious hair growth on mice.

The Knoevenagel condensation using quinine as an organocatalyst under solvent-free conditions

Jain, Kavita,Chaudhuri, Saikat,Pal, Kuntal,Das, Kalpataru

supporting information, p. 1299 - 1304 (2019/01/21)

The Knoevenagel condensation between active methylene compounds and aromatic carobonyl compounds has been developed using quinine as an organocatalyst to afford various electrophilic alkenes in excellent yields (up to 90%). In the presence of a catalytic amount of quinine (15 mol%), the reaction proceeded at room temperature (RT) under solvent-free conditions. In this green approach, the organocatalyst was recovered and recycled for up to four cycles without appreciable loss of activity.

Kinetic insights of DNA/RNA segment salts catalyzed knoevenagel condensation reaction

Li, Weina,Fedosov, Sergey N.,Tan, Tianwei,Xu, Xuebing,Guo, Zheng

, p. 3294 - 3300 (2014/12/11)

In this work, we demonstrated that (i) salts of RNA/DNA segments were capable of catalyzing Knoevenagel condensation at physiological pH 7.0 with efficiency comparable to one of the best enzymes, porcine pancreatic lipase (PPL); and (ii) a broad scope of

Determination of thermodynamic affinities of various polar olefins as hydride, hydrogen atom, and electron acceptors in acetonitrile

Cao, Ying,Zhang, Song-Chen,Zhang, Min,Shen, Guang-Bin,Zhu, Xiao-Qing

, p. 7154 - 7168 (2013/08/23)

A series of 69 polar olefins with various typical structures (X) were synthesized and the thermodynamic affinities (defined in terms of the molar enthalpy changes or the standard redox potentials in this work) of the polar olefins obtaining hydride anions, hydrogen atoms, and electrons, the thermodynamic affinities of the radical anions of the polar olefins (X ?-) obtaining protons and hydrogen atoms, and the thermodynamic affinities of the hydrogen adducts of the polar olefins (XH?) obtaining electrons in acetonitrile were determined using titration calorimetry and electrochemical methods. The pure Ci - 'C π-bond heterolytic and homolytic dissociation energies of the polar olefins (X) in acetonitrile and the pure Ci - 'C π-bond homolytic dissociation energies of the radical anions of the polar olefins (X?-) in acetonitrile were estimated. The remote substituent effects on the six thermodynamic affinities of the polar olefins and their related reaction intermediates were examined using the Hammett linear free-energy relationships; the results show that the Hammett linear free-energy relationships all hold in the six chemical and electrochemical processes. The information disclosed in this work could not only supply a gap of the chemical thermodynamics of olefins as one class of very important organic unsaturated compounds but also strongly promote the fast development of the chemistry and applications of olefins.

One-pot multistep cascade reactions over multifunctional nanocomposites with pd nanoparticles supported on amine-modified mesoporous silica

Li, Ping,Liu, Hua,Yu, Yu,Cao, Chang-Yan,Song, Wei-Guo

, p. 2459 - 2465 (2013/10/08)

Two kinds of multifunctional nanocomposites, SBA-15-NH2/Pd-p and SBA-15-NH2/Pd-f, with platelet-like and fiber-like morphologies, respectively, were fabricated by immobilizing Pd NPs onto amine-functionalized SBA-15. Some of the amino groups acted as anchoring sites for Pd NPs, whilst the remaining groups acted as Bronsted basic sites. As a result, the composites served as excellent multifunctional heterogeneous catalysts for one-pot multistep cascade reaction sequences. Moreover,when diffusion was the rate-determine step, SBA-15-NH2/Pd-p, with small mesopores, was superior to the fiber-like control sample, owing to its short diffusion length, a lower possibility of pore clogging, and better mass transportation for the reaction species during the catalysis.

Organic amine grafting on mesoporous silica as a hybrid catalyst for heterogeneous three-component one-pot reaction

Komura, Kenichi,Mishima, Yuta,Koketsu, Mamoru

, p. 128 - 132 (2013/02/21)

The organic-inorganic hybrid catalyst was prepared by immobilizing 3-methylaminopropyl moiety onto mesoporous silica, MCM-41, and applied for solid base catalyst of three-component one-pot reaction, i.e. Knoevenagel condensation of aldehyde with the active methylene compound to yield an electron deficient alkene which is subjective to be reacted with nitromethane by Michael addition to form tri-substituted primary nitro compound. The catalyst was characterized by powder-XRD, TG-DTA, FT-IR, nitrogen adsorption-desorption measurement and solid-state cross polarization magic angle spinning (CP/MAS) NMR, and exhibited high catalytic activity in three-component one-pot reaction; however, with poor reusability.

Efficient asymmetric synthesis of 4H-chromene derivatives through a tandem michael addition-cyclization reaction catalyzed by a salen-cobalt(II) complex

Dong, Zhenhua,Liu, Xiaohua,Feng, Juhua,Wang, Min,Lin, Lili,Feng, Xiaoming

supporting information; experimental part, p. 137 - 142 (2011/03/18)

The asymmetric synthesis of 2-amino-5-oxo-5,6,7,8-tetrahydro-4H-chromene derivatives was achieved through a tandem Michael addition-cyclization reaction of easily available cyclohexane-1,3-dione and ethyl 2-cyano-3-phenylacrylates. Moderate to good yields (up to 81%) and high enantioselectivities (up to 89%ee) were obtained with a chiral salen-cobalt(II) complex. This process was air tolerant and easily performed, which provides an efficient method for the synthesis of chiral 4H-chromene derivatives. The asymmetric synthesis of 2-amino-5-oxo-5,6,7,8-tetrahydro-4H-chromene derivatives was achieved through a tandem Michael addition-cyclization reaction of easily available cyclohexane-1,3-dione and ethyl 2-cyano-3-phenylacrylates catalyzed by a chiral salen-cobalt(II) complex with moderate to good yields (up to 81%) and high enantioselectivities (up to 89%ee).

NITROGENATED HETEROCYCLIC COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME

-

Page/Page column 26, (2008/12/06)

The present invention relates to novel compounds having a xanthine oxidase inhibitory effect and an uricosuric effect and pharmaceutical compositions comprising the same as an active ingredient. That is, the present invention relates nitrogen-containing heterocyclic compounds represented by the following general formula (I): wherein Y1 represents N or C(R4) ; Y2 represents N or C(R5) ; R4 and R5 independently represent an alkyl group, a hydrogen atom etc. ; one of R1 and R2 represents an optionally substituted aryl group, an alkoxygroup or an optionally substituted heterocyclic group; the other of R1 and R2 represents a haloalkyl group, a cyanogroup, ahalogenatometc.; and R3 represents a 5-tetrazolyl group or a carboxy group, and pharmaceutically acceptable salts thereof, and pharmaceutical compositions comprising the same as an active ingredient.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 149550-21-0